Haema 2011; 2(3): 235-243
by Dimitris Loukopoulos
Professor, Medical School, University of Athens
Author: admin
The molecular Basis of Thalassemia Syndromes
Haema 2011; 2(3): 225-234
by Joanne Traeger-Synodinos1, Christina Vrettou1,2, Manousos Papadakis3, Emmanuel Kanavakis1,2
1Laboratory of Medical Genetics, University of Athens, Choremeio Research Laboratory,
2Research Institute for the Study of Genetic and Malignant Disorders in Childhood, Aghia Sophia’s Children’s Hospital, Athens,
3Laboratory for Prenatal Diagnosis, Laiko Hospital, Athens, Greece
Continue reading “The molecular Basis of Thalassemia Syndromes”
Myelodysplastic Syndromes with deletion of the long arm of chromosome 5 and del-5q syndrome
Haema 2011; 2(2): 205-213
by Αrgiris S. Symeonidis
Associate Professor Hematology University of Patras, Greece
The role of flow cytometry in the diagnosis of myelodysplastic syndromes
Haema 2011; 2(2): 193-204
by Μarina Κarakantza1, Aikaterini Psarra2
1Haematology Department of University Hospital, Medical School, Patras, 2Department of Immunology – Histocompatibility, Evangelismos, Αthens
Continue reading “The role of flow cytometry in the diagnosis of myelodysplastic syndromes”
Pathology of myelodysplastic syndromes
Haema 2011; 2(2): 187-192
by Helen P. Kourea,1, Anna Tasidou2
1University of Patras Medical School, University Hospital, Department of Pathology, 2Department of Haemopathology, Evaggelismos General Hospital of Athens
Cytogenetic abnormalities in myelodysplastic syndromes: Clinical and prognostic impact
Haema 2011; 2(2): 177-186
by Charikleia Κelaidi1, Constantina Sabani2
1Department of Haematology and Bone Marrow Transplantation, G. Papanikolaou Hospital, Thessaloniki, Greece
2Laboratory of Health Physics & Environmental Health, National Center for Scientific Research “Demokritos”, Athens, Greece.
Pathogenesis of MDS III: The role of epigenetic modifications
Haema 2011; 2(2): 169-176
by Eleftheria Hatzimichael, Leonidas Benetatos, Evangelos Briasoulis
Department of Haematology, University Hospital of Ioannina
Continue reading “Pathogenesis of MDS III: The role of epigenetic modifications”
Pathogenesis of myelodysplastic syndromes II: The role of the immune system
Haema 2011; 2(2): 162-168
Michael Voulgarelis, Ioanna Vlahadami, Katerina Benekou
Department of Pathophysiology, University of Athens Medical School
Continue reading “Pathogenesis of myelodysplastic syndromes II: The role of the immune system”
Pathogenetic aspects of MDS: the role of apoptosis
Haema 2011; 2(2): 153-161
by Agapi Parcharidou1, Panagiota Tsoplou2, Αrgiris Symeonidis3
13rd Dept of Internal Medicine, Korgialeneio-Benakeio Hospital of Athens,
2BIOIATRIKI Laboratories, Dept of Human Genetics, Athens,
3Hematology Division, Dept of Internal Medicine, University of Patras Medical School, Patras.
Continue reading “Pathogenetic aspects of MDS: the role of apoptosis”
MDS classification: an appraisal
Haema 2011; 2(2): 144-152
by Ioannis Kotsianidis, Evagelia Nakou, Paraskevi Miltiadi
Hematology department, Democritus Thrace University, Medical school, Alexandroupolis
History and Epidemiology of Myelodysplastic Syndromes
Haema 2011; 2(2): 136-143
by Maria Papaioannou, Sofia Mpampali, George Karamarias
1st Department of Internal Medicine, Hematology Dept, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece
Continue reading “History and Epidemiology of Myelodysplastic Syndromes”
The role of splenectomy in the treatment of immune thrombocytopenia
Haema 2010; 1(2): 204-214
by Katerina Megalakaki
Department of Haematology, Metaxa Cancer Hospital, Piraeus, Greece
Continue reading “The role of splenectomy in the treatment of immune thrombocytopenia”
The role of monoclonal antibodies in the treatment of primary immune thrombocytopenia
Haema 2010; 1(2): 195-203
by Stavroula Masouridi MD and Photis Beris MD.
University Hematology Clinic, Laikon General Hospital, School of Medicine, National and Kapodistrian University of Athens – Greece.
Novel thrombopoietic agents in the treatment of primary immune thrombocytopenia
Haema 2010; 1(2): 183-194
by Charalampos Pontikoglou
Heamatology Department, University of Crete School of Medicine, Heraklion, Greece, Establishment Français du Sang Centre-Atlantique, Research Dept, EA3855. GECSoM, Tours, France.
Continue reading “Novel thrombopoietic agents in the treatment of primary immune thrombocytopenia”
Guidelines for the treatment of the primary immune thrombocytopenia in adults
Haema 2010; 1(2): 172-182
by Maria Papaioannou, Dimitrios Pilalas
Department of Haematology, First Department of Internal Medicine, AHEPA University Hospital Aristotle University of Thessaloniki School of Medicine
Continue reading “Guidelines for the treatment of the primary immune thrombocytopenia in adults”